{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T04:26:02Z","timestamp":1769660762940,"version":"3.49.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000084","name":"Directorate for Engineering","doi-asserted-by":"publisher","award":["2137423"],"award-info":[{"award-number":["2137423"]}],"id":[{"id":"10.13039\/100000084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020065","name":"San Antonio Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Trauma Research and Combat Casualty Care Collaborative"},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG064420"],"award-info":[{"award-number":["R01AG064420"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Regen. Eng. Transl. Med."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s40883-025-00421-0","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T12:29:05Z","timestamp":1747052945000},"page":"849-863","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Delivery of Nucleic Acids for Vascular Tissue Engineering Applications"],"prefix":"10.1007","volume":"11","author":[{"given":"Jordyn M.","family":"Wyse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscilla","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Miserlis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Koutakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marissa E.","family":"Wechsler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"issue":"12","key":"421_CR1","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1161\/CIRCRESAHA.121.318535","volume":"128","author":"AW Aday","year":"2021","unstructured":"Aday AW, Matsushita K. Epidemiology of peripheral artery disease and polyvascular disease. Circ Res. 2021;128(12):1818\u201332. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318535.","journal-title":"Circ Res"},{"key":"421_CR2","doi-asserted-by":"publisher","unstructured":"D. Deshpande, D. R. Janero, V. Segura-Ibarra, E. Blanco, and M. M. Amiji, 2016 \u201cNucleic acid delivery for endothelial dysfunction in cardiovascular diseases,\u201d 2016. https:\/\/doi.org\/10.14797\/mdcj-12-3-134.","DOI":"10.14797\/mdcj-12-3-134"},{"key":"421_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11883-020-0826-2","volume":"22","author":"P M\u00e4kinen","year":"2020","unstructured":"M\u00e4kinen P, Ruotsalainen AK, Yl\u00e4-Herttuala S. Nucleic acid\u2013based therapies for atherosclerosis. Curr Atheroscler Rep. 2020;22:1\u20138. https:\/\/doi.org\/10.1007\/s11883-020-0826-2.","journal-title":"Curr Atheroscler Rep"},{"key":"421_CR4","doi-asserted-by":"publisher","unstructured":"J. Han, L. Luo, O. Marcelina, V. Kasim, and S. Wu, 2022 \u201cTherapeutic angiogenesis-based strategy for peripheral artery disease,\u201d 2022. https:\/\/doi.org\/10.7150\/thno.74785.","DOI":"10.7150\/thno.74785"},{"issue":"7","key":"421_CR5","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/mt.2012.79","volume":"20","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Satterlee A, Huang L. In vivo gene delivery by nonviral vectors: overcoming hurdles. Mol Ther. 2012;20(7):1298\u2013304. https:\/\/doi.org\/10.1038\/mt.2012.79.","journal-title":"Mol Ther"},{"issue":"7","key":"421_CR6","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1021\/ar3000162","volume":"45","author":"J Nguyen","year":"2012","unstructured":"Nguyen J, Szoka FC. Nucleic acid delivery: the missing pieces of the puzzle? Acc Chem Res. 2012;45(7):1153\u201362. https:\/\/doi.org\/10.1021\/ar3000162.","journal-title":"Acc Chem Res"},{"issue":"2\u20133","key":"421_CR7","first-page":"106","volume":"7","author":"L Fischer","year":"2002","unstructured":"Fischer L, Preis M, Weisz A, Koren B, Lewis BS, Flugelman MY. Viral vectors for vascular gene therapy. Exp Clin Cardiol. 2002;7(2\u20133):106\u201312.","journal-title":"Exp Clin Cardiol"},{"issue":"1","key":"421_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0167-7799(97)01137-2","volume":"80","author":"PD Robbins","year":"1998","unstructured":"Robbins PD, Ghivizzani SC. Viral vectors for gene therapy. Pharmacol Ther. 1998;80(1):35\u201347. https:\/\/doi.org\/10.1016\/S0167-7799(97)01137-2.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"421_CR9","first-page":"1","volume":"36","author":"L Vannucci","year":"2013","unstructured":"Vannucci L, Lai M, Chiuppesi F, Ceccherini-Nelli L, Pistello M. Viral vectors: a look back and ahead on gene transfer technology. New Microbiol. 2013;36(1):1\u201322.","journal-title":"New Microbiol"},{"key":"421_CR10","doi-asserted-by":"publisher","first-page":"113834","DOI":"10.1016\/j.addr.2021.113834","volume":"178","author":"A Gupta","year":"2021","unstructured":"Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021;178:113834. https:\/\/doi.org\/10.1016\/j.addr.2021.113834.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"421_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s43586-022-00104-y","volume":"2","author":"BB Mendes","year":"2022","unstructured":"Mendes BB, et al. Nanodelivery of nucleic acids. Nat Rev Methods Primers. 2022;2(1):24. https:\/\/doi.org\/10.1038\/s43586-022-00104-y.","journal-title":"Nat Rev Methods Primers"},{"key":"421_CR12","doi-asserted-by":"publisher","unstructured":"J. Belgrad, H. H. Fakih, and A. Khvorova, 2024 \u201cNucleic acid therapeutics: successes, milestones, and upcoming innovation,\u201d https:\/\/doi.org\/10.1089\/nat.2023.0068.","DOI":"10.1089\/nat.2023.0068"},{"issue":"3","key":"421_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1056\/nejmoa1701329","volume":"377","author":"MJ Graham","year":"2017","unstructured":"Graham MJ, et al. Cardiovascular and metabolic effects of ANGPTL3 antisense oligonucleotides. N Engl J Med. 2017;377(3):222\u201332. https:\/\/doi.org\/10.1056\/nejmoa1701329.","journal-title":"N Engl J Med"},{"issue":"3","key":"421_CR14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.12997\/jla.2022.11.3.250","volume":"11","author":"K Kim","year":"2022","unstructured":"Kim K, Choi SH. A new modality in dyslipidemia treatment: antisense oligonucleotide therapy. J Lipid Atheroscler. 2022;11(3):250\u201361. https:\/\/doi.org\/10.12997\/jla.2022.11.3.250.","journal-title":"J Lipid Atheroscler"},{"issue":"5","key":"421_CR15","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/jth.14755","volume":"18","author":"S Zhu","year":"2020","unstructured":"Zhu S, et al. The development and characterization of a long acting anti-thrombotic von Willebrand factor (VWF) aptamer. J Thromb Haemost. 2020;18(5):1113\u201323. https:\/\/doi.org\/10.1111\/jth.14755.","journal-title":"J Thromb Haemost"},{"key":"421_CR16","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.omtn.2022.08.007","volume":"29","author":"SK Yazdani","year":"2022","unstructured":"Yazdani SK, et al. Local intraluminal delivery of a smooth muscle-targeted RNA ligand inhibits neointima growth in a porcine model of peripheral vascular disease. Mol Ther Nucleic Acids. 2022;29:577\u201383. https:\/\/doi.org\/10.1016\/j.omtn.2022.08.007.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"421_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40256-016-0210-3","volume":"17","author":"R Deev","year":"2017","unstructured":"Deev R, Plaksa I, Bozo I, Isaev A. Results of an international postmarketing surveillance study of pl-VEGF165 safety and efficacy in 210 patients with peripheral arterial disease. Am J Cardiovasc Drugs. 2017;17(3):235. https:\/\/doi.org\/10.1007\/s40256-016-0210-3.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"5","key":"421_CR18","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1067\/mva.2002.123677","volume":"35","author":"AJ Comerota","year":"2002","unstructured":"Comerota AJ, et al. \u201cNaked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: preliminary results of a phase I trial. J Vasc Surg. 2002;35(5):930\u20136. https:\/\/doi.org\/10.1067\/mva.2002.123677.","journal-title":"J Vasc Surg"},{"issue":"1","key":"421_CR19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.chembiol.2011.12.008","volume":"19","author":"JC Burnett","year":"2012","unstructured":"Burnett JC, Rossi JJ. RNA-based therapeutics: current progress and future prospects. Chem Biol. 2012;19(1):60\u201371. https:\/\/doi.org\/10.1016\/j.chembiol.2011.12.008.","journal-title":"Chem Biol"},{"issue":"3","key":"421_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ncb0309-228","volume":"11","author":"J Winter","year":"2009","unstructured":"Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009;11(3):228\u201334. https:\/\/doi.org\/10.1038\/ncb0309-228.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"421_CR21","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1161\/CIRCRESAHA.115.306300","volume":"118","author":"MW Feinberg","year":"2016","unstructured":"Feinberg MW, Moore KJ. MicroRNA regulation of atherosclerosis. Circ Res. 2016;118(4):703\u201320. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306300.","journal-title":"Circ Res"},{"issue":"2","key":"421_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281\u201397. https:\/\/doi.org\/10.1016\/S0092-8674(04)00045-5.","journal-title":"Cell"},{"issue":"8","key":"421_CR23","doi-asserted-by":"publisher","first-page":"698","DOI":"10.2174\/156652408786733739","volume":"8","author":"N Asli","year":"2008","unstructured":"Asli N, Pitulescu M, Kessel M. MicroRNAs in organogenesis and disease. Curr Mol Med. 2008;8(8):698. https:\/\/doi.org\/10.2174\/156652408786733739.","journal-title":"Curr Mol Med"},{"issue":"4","key":"421_CR24","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/jcp.22422","volume":"226","author":"NJ Leeper","year":"2011","unstructured":"Leeper NJ, et al. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol. 2011;226(4):1035. https:\/\/doi.org\/10.1002\/jcp.22422.","journal-title":"J Cell Physiol"},{"issue":"9","key":"421_CR25","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1161\/CIRCRESAHA.119.316317","volume":"127","author":"NI Mar\u00edn-Ramos","year":"2020","unstructured":"Mar\u00edn-Ramos NI, Thein TZ, Ghaghada KB, Chen TC, Giannotta SL, Hofman FM. MiR-18a inhibits BMP4 and HIF-1\u03b1 normalizing brain arteriovenous malformations. Circ Res. 2020;127(9):e210-31. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.316317.","journal-title":"Circ Res"},{"issue":"7","key":"421_CR26","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/s12276-023-00998-y","volume":"55","author":"I Ahn","year":"2023","unstructured":"Ahn I, Kang CS, Han J. Where should siRNAs go: applicable organs for siRNA drugs. Exp Mol Med. 2023;55(7):1283\u201392. https:\/\/doi.org\/10.1038\/s12276-023-00998-y.","journal-title":"Exp Mol Med"},{"issue":"2","key":"421_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/ki.2013.290","volume":"85","author":"B Yang","year":"2014","unstructured":"Yang B, et al. Adventitial transduction of lentivirus-shRNA-VEGF-A in arteriovenous fistula reduces venous stenosis formation. Kidney Int. 2014;85(2):289. https:\/\/doi.org\/10.1038\/ki.2013.290.","journal-title":"Kidney Int"},{"issue":"21","key":"421_CR28","doi-asserted-by":"publisher","first-page":"11596","DOI":"10.3390\/ijms222111596","volume":"22","author":"M Hueso","year":"2021","unstructured":"Hueso M, Mall\u00e9n A, Su\u00f1\u00e9-pou M, Aran JM, Su\u00f1\u00e9-negre JM, Navarro E. Ncrnas in therapeutics: challenges and limitations in nucleic acid-based drug delivery. Int J Mol Sci. 2021;22(21):11596. https:\/\/doi.org\/10.3390\/ijms222111596.","journal-title":"Int J Mol Sci"},{"key":"421_CR29","doi-asserted-by":"publisher","unstructured":"X. Bian et al., \u201cEmerging delivery systems for enabling precision nucleic acid therapeutics,\u201d Feb. 04, 2025, American Chemical Society. https:\/\/doi.org\/10.1021\/acsnano.4c11858.","DOI":"10.1021\/acsnano.4c11858"},{"key":"421_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2012.06.036","author":"HC Kang","year":"2012","unstructured":"Kang HC, Huh KM, Bae YH. Polymeric nucleic acid carriers: current issues and novel design approaches. J Control Release. 2012. https:\/\/doi.org\/10.1016\/j.jconrel.2012.06.036.","journal-title":"J Control Release"},{"key":"421_CR31","doi-asserted-by":"publisher","first-page":"114895","DOI":"10.1016\/j.addr.2023.114895","volume":"198","author":"P Wen","year":"2023","unstructured":"Wen P, Ke W, Dirisala A, Toh K, Tanaka M, Li J. Stealth and pseudo-stealth nanocarriers. Adv Drug Deliv Rev. 2023;198:114895. https:\/\/doi.org\/10.1016\/j.addr.2023.114895.","journal-title":"Adv Drug Deliv Rev"},{"key":"421_CR32","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.addr.2012.09.014","volume":"64","author":"J Kost","year":"2012","unstructured":"Kost J, Langer R. Responsive polymeric delivery systems. Adv Drug Deliv Rev. 2012;64:327\u201341. https:\/\/doi.org\/10.1016\/j.addr.2012.09.014.","journal-title":"Adv Drug Deliv Rev"},{"key":"421_CR33","doi-asserted-by":"publisher","first-page":"113885","DOI":"10.1016\/j.addr.2021.113885","volume":"176","author":"Y Zhuang","year":"2021","unstructured":"Zhuang Y, Cui W. Biomaterial-based delivery of nucleic acids for tissue regeneration. Adv Drug Deliv Rev. 2021;176:113885. https:\/\/doi.org\/10.1016\/j.addr.2021.113885.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"421_CR34","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/wnan.1304","volume":"7","author":"Z Lin","year":"2015","unstructured":"Lin Z, Monteiro-Riviere NA, Riviere JE. Pharmacokinetics of metallic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015;7(2):189\u2013217. https:\/\/doi.org\/10.1002\/wnan.1304.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"1","key":"421_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s43586-022-00104-y","volume":"2","author":"BB Mendes","year":"2022","unstructured":"Mendes BB, et al. Nanodelivery of nucleic acids. Nat Rev Methods Primers. 2022;2(1):24. https:\/\/doi.org\/10.1038\/s43586-022-00104-y.","journal-title":"Nat Rev Methods Primers"},{"key":"421_CR36","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.addr.2006.03.001","volume":"58","author":"JM Dang","year":"2006","unstructured":"Dang JM, Leong KW. Natural polymers for gene delivery and tissue engineering. Adv Drug Deliv Rev. 2006;58:487\u201399. https:\/\/doi.org\/10.1016\/j.addr.2006.03.001.","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"421_CR37","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/sj.gt.3302918","volume":"14","author":"RM Capito","year":"2007","unstructured":"Capito RM, Spector M. Collagen scaffolds for nonviral IGF-1 gene delivery in articular cartilage tissue engineering. Gene Ther. 2007;14(9):721\u201332. https:\/\/doi.org\/10.1038\/sj.gt.3302918.","journal-title":"Gene Ther"},{"issue":"4","key":"421_CR38","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3390\/polym10040462","volume":"10","author":"D Zhao","year":"2018","unstructured":"Zhao D, Yu S, Sun B, Gao S, Guo S, Zhao K. Biomedical applications of chitosan and its derivative nanoparticles. Polymers. 2018;10(4):462. https:\/\/doi.org\/10.3390\/polym10040462.","journal-title":"Polymers"},{"issue":"4","key":"421_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/pharmaceutics9040053","volume":"9","author":"MA Mohammed","year":"2017","unstructured":"Mohammed MA, Syeda JTM, Wasan KM, Wasan EK. An overview of chitosan nanoparticles and its application in non-parenteral drug delivery. Pharmaceutics. 2017;9(4):53. https:\/\/doi.org\/10.3390\/pharmaceutics9040053.","journal-title":"Pharmaceutics"},{"key":"421_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/adhm.202101867","volume":"2101867","author":"E Kurt","year":"2021","unstructured":"Kurt E, Segura T. Nucleic acid delivery from granular hydrogels. Adv Healthc Mater. 2021;2101867:1\u201316. https:\/\/doi.org\/10.1002\/adhm.202101867.","journal-title":"Adv Healthc Mater"},{"issue":"12","key":"421_CR41","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/mabi.201300302","volume":"13","author":"A Almalik","year":"2013","unstructured":"Almalik A, Day PJ, Tirelli N. HA-coated chitosan nanoparticles for CD44-mediated nucleic acid delivery. Macromol Biosci. 2013;13(12):1671\u201380. https:\/\/doi.org\/10.1002\/mabi.201300302.","journal-title":"Macromol Biosci"},{"issue":"5","key":"421_CR42","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/17425247.2022.2075845","volume":"19","author":"OS Muddineti","year":"2022","unstructured":"Muddineti OS, Omri A. \u201cCurrent trends in PLGA based long-acting injectable products: the industry perspective. Expert Opin Drug Deliv. 2022;19(5):559\u201376. https:\/\/doi.org\/10.1080\/17425247.2022.2075845.","journal-title":"Expert Opin Drug Deliv"},{"key":"421_CR43","doi-asserted-by":"publisher","unstructured":"J. M. Wyse, B. A. Sullivan, P. Lopez, T. Guda, C. R. Rathbone, and M. E. Wechsler, \u201cPoly(lactic-co-glycolic acid) microparticles for the delivery of model drug compounds for applications in vascular tissue engineering,\u201d Cells Tissues Organs, pp. 1\u201311, Jun. 2024, https:\/\/doi.org\/10.1159\/000539971.","DOI":"10.1159\/000539971"},{"issue":"5","key":"421_CR44","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/J.BIOMATERIALS.2006.09.047","volume":"28","author":"J Cheng","year":"2007","unstructured":"Cheng J, et al. Formulation of functionalized PLGA\u2013PEG nanoparticles for in vivo targeted drug delivery. Biomaterials. 2007;28(5):869\u201376. https:\/\/doi.org\/10.1016\/J.BIOMATERIALS.2006.09.047.","journal-title":"Biomaterials"},{"key":"421_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2025.02.056","author":"CY Lin","year":"2025","unstructured":"Lin CY, Fang JY, Hsiao CY, Lee CW, Alshetaili A, Lin ZC. Dual cell-penetrating peptide-conjugated polymeric nanocarriers for miRNA-205\u20135p delivery in gene therapy of cutaneous squamous cell carcinoma. Acta Biomater. 2025. https:\/\/doi.org\/10.1016\/j.actbio.2025.02.056.","journal-title":"Acta Biomater"},{"key":"421_CR46","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0169-409X(02)00180-1","volume":"55","author":"RB Greenwald","year":"2003","unstructured":"Greenwald RB, Choe YH, Mcguire J, Conover CD. Effective drug delivery by PEGylated drug conjugates. Adv Drug Deliv Rev. 2003;55:217\u201350.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"421_CR47","doi-asserted-by":"publisher","first-page":"e10600","DOI":"10.1002\/btm2.10600","volume":"9","author":"Y Gao","year":"2024","unstructured":"Gao Y, Joshi M, Zhao Z, Mitragotri S. PEGylated therapeutics in the clinic. Bioeng Transl Med. 2024;9(1):e10600. https:\/\/doi.org\/10.1002\/btm2.10600.","journal-title":"Bioeng Transl Med"},{"issue":"3","key":"421_CR48","doi-asserted-by":"publisher","first-page":"1900170","DOI":"10.1002\/adtp.201900170","volume":"3","author":"N d\u2019Avanzo","year":"2020","unstructured":"d\u2019Avanzo N, et al. Immunogenicity of polyethylene glycol based nanomedicines: mechanisms, clinical implications and systematic approach. Adv Ther. 2020;3(3):1900170. https:\/\/doi.org\/10.1002\/adtp.201900170.","journal-title":"Adv Ther"},{"key":"421_CR49","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jconrel.2022.09.031","volume":"351","author":"M Ibrahim","year":"2022","unstructured":"Ibrahim M, et al. Polyethylene glycol (PEG): the nature, immunogenicity, and role in the hypersensitivity of PEGylated products. J Control Release. 2022;351:215\u201330. https:\/\/doi.org\/10.1016\/j.jconrel.2022.09.031.","journal-title":"J Control Release"},{"issue":"46","key":"421_CR50","doi-asserted-by":"publisher","first-page":"21304","DOI":"10.1021\/jacs.2c09232","volume":"144","author":"R D\u2019Arcy","year":"2022","unstructured":"D\u2019Arcy R, et al. A reactive oxygen species-scavenging stealth\u2019 polymer, poly(thioglycidyl glycerol), outperforms poly(ethylene glycol) in protein conjugates and nanocarriers and enhances protein stability to environmental and biological stressors. J Am Chem Soc. 2022;144(46):21304\u201317. https:\/\/doi.org\/10.1021\/jacs.2c09232.","journal-title":"J Am Chem Soc"},{"issue":"1\u20132","key":"421_CR51","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/J.IJPHARM.2008.09.039","volume":"367","author":"Y Patil","year":"2009","unstructured":"Patil Y, Panyam J. Polymeric nanoparticles for siRNA delivery and gene silencing. Int J Pharm. 2009;367(1\u20132):195. https:\/\/doi.org\/10.1016\/J.IJPHARM.2008.09.039.","journal-title":"Int J Pharm"},{"key":"421_CR52","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jconrel.2023.03.011","volume":"356","author":"F Joubert","year":"2023","unstructured":"Joubert F, et al. Precise and systematic end group chemistry modifications on PAMAM and poly(L-lysine) dendrimers to improve cytosolic delivery of mRNA. J Control Release. 2023;356:580. https:\/\/doi.org\/10.1016\/j.jconrel.2023.03.011.","journal-title":"J Control Release"},{"issue":"3","key":"421_CR53","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1039\/d4bm01290a","volume":"13","author":"S Chen","year":"2025","unstructured":"Chen S, Pinto Carneiro S, Merkel OM. Anionic polymer coating for enhanced delivery of Cas9 mRNA and sgRNA nanoplexes. Biomater Sci. 2025;13(3):659\u201376. https:\/\/doi.org\/10.1039\/d4bm01290a.","journal-title":"Biomater Sci"},{"issue":"2","key":"421_CR54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0378-5173(97)00135-X","volume":"154","author":"A Sharma","year":"1997","unstructured":"Sharma A, Sharma US. Liposomes in drug delivery: progress and limitations. Int J Pharmaceutics. 1997;154(2):123\u201340.","journal-title":"Int J Pharmaceutics"},{"issue":"11","key":"421_CR55","doi-asserted-by":"publisher","first-page":"5164","DOI":"10.1039\/c4nj01314j","volume":"38","author":"CR Safinya","year":"2014","unstructured":"Safinya CR, Ewert KK, Majzoub RN, Leal C. Cationic liposome-nucleic acid complexes for gene delivery and gene silencing. New J Chem. 2014;38(11):5164\u201372. https:\/\/doi.org\/10.1039\/c4nj01314j.","journal-title":"New J Chem"},{"issue":"3","key":"421_CR56","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s11095-006-9180-5","volume":"24","author":"W Li","year":"2007","unstructured":"Li W, Szoka FC. Lipid-based nanoparticles for nucleic acid delivery. Pharm Res. 2007;24(3):438\u201349. https:\/\/doi.org\/10.1007\/s11095-006-9180-5.","journal-title":"Pharm Res"},{"issue":"10","key":"421_CR57","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","volume":"55","author":"Y Lee","year":"2023","unstructured":"Lee Y, Jeong M, Park J, Jung H, Lee H. Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics. Exp Mol Med. 2023;55(10):2085\u201396. https:\/\/doi.org\/10.1038\/s12276-023-01086-x.","journal-title":"Exp Mol Med"},{"key":"421_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202413220","author":"TH Cheung","year":"2024","unstructured":"Cheung TH, Fuchs A, Shoichet MS. Acid-responsive polymer additives increase RNA transfection from lipid nanoparticles. Adv Funct Mater. 2024. https:\/\/doi.org\/10.1002\/adfm.202413220.","journal-title":"Adv Funct Mater"},{"key":"421_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41563-024-02116-3","author":"Y Xiao","year":"2025","unstructured":"Xiao Y, et al. High-density brush-shaped polymer lipids reduce anti-PEG antibody binding for repeated administration of mRNA therapeutics. Nat Mater. 2025. https:\/\/doi.org\/10.1038\/s41563-024-02116-3.","journal-title":"Nat Mater"},{"issue":"2020","key":"421_CR60","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.addr.2020.06.020","volume":"156","author":"DC Luther","year":"2020","unstructured":"Luther DC, et al. Delivery of drugs, proteins, and nucleic acids using inorganic nanoparticles. Adv Drug Deliv Rev. 2020;156(2020):188\u2013213. https:\/\/doi.org\/10.1016\/j.addr.2020.06.020.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"421_CR61","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/mt.2014.30","volume":"22","author":"Y Ding","year":"2014","unstructured":"Ding Y, et al. Gold nanoparticles for nucleic acid delivery. Mol Ther. 2014;22(6):1075\u201383. https:\/\/doi.org\/10.1038\/mt.2014.30.","journal-title":"Mol Ther"},{"issue":"1","key":"421_CR62","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11051-009-9692-0","volume":"12","author":"CL Villiers","year":"2010","unstructured":"Villiers CL, Freitas H, Couderc R, Villiers MB, Marche PN. Analysis of the toxicity of gold nano particles on the immune system: effect on dendritic cell functions. J Nanopart Res. 2010;12(1):55\u201360. https:\/\/doi.org\/10.1007\/s11051-009-9692-0.","journal-title":"J Nanopart Res"},{"issue":"4","key":"421_CR63","doi-asserted-by":"publisher","first-page":"e23535","DOI":"10.1002\/bip.23535","volume":"114","author":"B \u00c7a\u011fda\u015f Tunal\u0131","year":"2023","unstructured":"\u00c7a\u011fda\u015f Tunal\u0131 B, \u00c7elik E, Budak Y\u0131ld\u0131ran FA, T\u00fcrk M. Delivery of siRNA using hyaluronic acid-guided nanoparticles for downregulation of CXCR4. Biopolymers. 2023;114(4):e23535. https:\/\/doi.org\/10.1002\/bip.23535.","journal-title":"Biopolymers"},{"issue":"1\u20132","key":"421_CR64","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ijpharm.2007.11.002","volume":"354","author":"K Tahara","year":"2008","unstructured":"Tahara K, Sakai T, Yamamoto H, Takeuchi H, Kawashima Y. Establishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene delivery. Int J Pharm. 2008;354(1\u20132):210\u20136. https:\/\/doi.org\/10.1016\/j.ijpharm.2007.11.002.","journal-title":"Int J Pharm"},{"issue":"6","key":"421_CR65","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.1021\/NN300106T","volume":"6","author":"M Chen","year":"2012","unstructured":"Chen M, et al. Chitosan\/siRNA nanoparticles encapsulated in PLGA nanofibers for siRNA delivery. ACS Nano. 2012;6(6):4835\u201344. https:\/\/doi.org\/10.1021\/NN300106T.","journal-title":"ACS Nano"},{"issue":"4","key":"421_CR66","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.7150\/thno.91829","volume":"14","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zhang M, Yan Z, Ji S, Xiao S, Gao J. Metal nanoparticle hybrid hydrogels: the state-of-the-art of combining hard and soft materials to promote wound healing. Theranostics. 2024;14(4):1534. https:\/\/doi.org\/10.7150\/thno.91829.","journal-title":"Theranostics"},{"key":"421_CR67","doi-asserted-by":"publisher","unstructured":"Y. Wang and L. Huang, \u201cComposite nanoparticles for gene delivery,\u201d in Advances in Genetics, vol. 88, 2014. https:\/\/doi.org\/10.1016\/B978-0-12-800148-6.00005-5.","DOI":"10.1016\/B978-0-12-800148-6.00005-5"},{"issue":"3","key":"421_CR68","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1021\/mp100390w","volume":"8","author":"X Su","year":"2011","unstructured":"Su X, Fricke J, Kavanagh DG, Irvine DJ. In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles. Mol Pharm. 2011;8(3):774. https:\/\/doi.org\/10.1021\/mp100390w.","journal-title":"Mol Pharm"},{"key":"421_CR69","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202407040","author":"J Li","year":"2024","unstructured":"Li J, et al. Zwitterionic polymer lipid nanoparticles enabling selective organ targeting delivery of small interfering RNA for the treatment of hepatic and pulmonary inflammation. Small. 2024. https:\/\/doi.org\/10.1002\/smll.202407040.","journal-title":"Small"},{"key":"421_CR70","doi-asserted-by":"publisher","first-page":"123063","DOI":"10.1016\/j.polymer.2020.123063","volume":"211","author":"KJ Hogan","year":"2020","unstructured":"Hogan KJ, Mikos AG. Biodegradable thermoresponsive polymers: applications in drug delivery and tissue engineering. Polymer (Guildf). 2020;211:123063. https:\/\/doi.org\/10.1016\/j.polymer.2020.123063.","journal-title":"Polymer (Guildf)"},{"key":"421_CR71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2018.10.006","volume":"138","author":"HD Do","year":"2019","unstructured":"Do HD, Couillaud BM, Doan BT, Corvis Y, Mignet N. Advances on non-invasive physically triggered nucleic acid delivery from nanocarriers. Adv Drug Deliv Rev. 2019;138:3\u201317. https:\/\/doi.org\/10.1016\/j.addr.2018.10.006.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"421_CR72","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1039\/d2lc00799a","volume":"23","author":"G Bashiri","year":"2023","unstructured":"Bashiri G, Padilla MS, Swingle KL, Shepherd SJ, Mitchell MJ, Wang K. Nanoparticle protein corona: from structure and function to therapeutic targeting. Lab on a Chip. 2023;23(6):1432\u201366. https:\/\/doi.org\/10.1039\/d2lc00799a.","journal-title":"Lab on a Chip"},{"issue":"5","key":"421_CR73","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1039\/c5cs00798d","volume":"45","author":"M Karimi","year":"2016","unstructured":"Karimi M, et al. Smart micro\/nanoparticles in stimulus-responsive drug\/gene delivery systems. Chem Soc Rev. 2016;45(5):1457\u2013501. https:\/\/doi.org\/10.1039\/c5cs00798d.","journal-title":"Chem Soc Rev"},{"issue":"13","key":"421_CR74","doi-asserted-by":"publisher","first-page":"1700030","DOI":"10.1002\/marc.201700030","volume":"38","author":"X Liu","year":"2017","unstructured":"Liu X, Yang Y, Urban MW. Stimuli-responsive polymeric nanoparticles. Macromol Rapid Commun. 2017;38(13):1700030. https:\/\/doi.org\/10.1002\/marc.201700030.","journal-title":"Macromol Rapid Commun"},{"key":"421_CR75","doi-asserted-by":"publisher","unstructured":"P. Gil-Cabrerizo, T. Simon-Yarza, E. Garbayo, and M. J. Blanco Prieto, \u201cNavigating the landscape of RNA delivery systems in cardiovascular disease therapeutics,\u201d May 01, 2024, Elsevier B.V. https:\/\/doi.org\/10.1016\/j.addr.2024.115302.","DOI":"10.1016\/j.addr.2024.115302"},{"issue":"5","key":"421_CR76","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","volume":"23","author":"K Paunovska","year":"2022","unstructured":"Paunovska K, Loughrey D, Dahlman JE. Drug delivery systems for RNA therapeutics. Nat Rev Genet. 2022;23(5):265\u201380. https:\/\/doi.org\/10.1038\/s41576-021-00439-4.","journal-title":"Nat Rev Genet"},{"key":"421_CR77","doi-asserted-by":"publisher","unstructured":"Ullah A, Khan M, Zhang Y, Shafiq M, Ullah M, Abbas A, Xianxiang X, Chen G, Diao Y., \u201cAdvancing therapeutic strategies with polymeric drug conjugates for nucleic acid delivery and treatment,\u201d 2025, Dove Medical Press Ltd. https:\/\/doi.org\/10.2147\/IJN.S429279.","DOI":"10.2147\/IJN.S429279"},{"issue":"1","key":"421_CR78","doi-asserted-by":"publisher","first-page":"110196","DOI":"10.1016\/j.celrep.2021.110196","volume":"38","author":"X Zhang","year":"2022","unstructured":"Zhang X, et al. Robust genome editing in adult vascular endothelium by nanoparticle delivery of CRISPR-Cas9 plasmid DNA. Cell Rep. 2022;38(1):110196. https:\/\/doi.org\/10.1016\/j.celrep.2021.110196.","journal-title":"Cell Rep"},{"issue":"5","key":"421_CR79","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1021\/bc0600968","volume":"17","author":"JJ Green","year":"2006","unstructured":"Green JJ, Shi J, Chiu E, Leshchiner ES, Langer R, Anderson DG. Biodegradable polymeric vectors for gene delivery to human endothelial cells. Bioconjug Chem. 2006;17(5):1162\u20139. https:\/\/doi.org\/10.1021\/bc0600968.","journal-title":"Bioconjug Chem"},{"issue":"3","key":"421_CR80","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jconrel.2008.05.017","volume":"132","author":"O Jeon","year":"2008","unstructured":"Jeon O, Yang HS, Lee TJ, Kim BS. Heparin-conjugated polyethylenimine for gene delivery. J Control Release. 2008;132(3):236\u201342. https:\/\/doi.org\/10.1016\/j.jconrel.2008.05.017.","journal-title":"J Control Release"},{"key":"421_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep25636","volume":"6","author":"J Chung","year":"2016","unstructured":"Chung J, et al. Discovery of novel peptides targeting pro-atherogenic endothelium in disturbed flow regions-targeted siRNA delivery to pro-atherogenic endothelium in vivo. Sci Rep. 2016;6:1\u201315. https:\/\/doi.org\/10.1038\/srep25636.","journal-title":"Sci Rep"},{"issue":"2","key":"421_CR82","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1096\/fj.13-238527","volume":"28","author":"J Devalliere","year":"2014","unstructured":"Devalliere J, et al. Sustained delivery of proangiogenic microRNA-132 by nanoparticle transfection improves endothelial cell transplantation. FASEB J. 2014;28(2):908\u201322. https:\/\/doi.org\/10.1096\/fj.13-238527.","journal-title":"FASEB J"},{"issue":"5","key":"421_CR83","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1021\/nl5048972","volume":"15","author":"OF Khan","year":"2015","unstructured":"Khan OF, et al. Dendrimer-inspired nanomaterials for the in vivo delivery of siRNA to lung vasculature. Nano Lett. 2015;15(5):3008\u201316. https:\/\/doi.org\/10.1021\/nl5048972.","journal-title":"Nano Lett"},{"issue":"2","key":"421_CR84","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jim.2008.12.005","volume":"343","author":"S Theoharis","year":"2009","unstructured":"Theoharis S, Krueger U, Tan PH, Haskard DO, Weber M, George AJT. Targeting gene delivery to activated vascular endothelium using anti E\/P-Selectin antibody linked to PAMAM dendrimers. J Immunol Methods. 2009;343(2):79\u201390. https:\/\/doi.org\/10.1016\/j.jim.2008.12.005.","journal-title":"J Immunol Methods"},{"key":"421_CR85","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jconrel.2021.09.012","volume":"338","author":"CA Mocanu","year":"2021","unstructured":"Mocanu CA, et al. P-selectin targeted RAGE-shRNA lipoplexes alleviate atherosclerosis-associated inflammation. J Control Release. 2021;338:754\u201372. https:\/\/doi.org\/10.1016\/j.jconrel.2021.09.012.","journal-title":"J Control Release"},{"issue":"2","key":"421_CR86","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jconrel.2011.09.080","volume":"160","author":"P Vader","year":"2012","unstructured":"Vader P, Crielaard BJ, Van Dommelen SM, Van Der Meel R, Storm G, Schiffelers RM. Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particles. J Control Release. 2012;160(2):211\u20136. https:\/\/doi.org\/10.1016\/j.jconrel.2011.09.080.","journal-title":"J Control Release"},{"issue":"18","key":"421_CR87","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/sj.gt.3302034","volume":"10","author":"M Lee","year":"2003","unstructured":"Lee M, Rentz J, Bikram M, Han S, Bull DA, Kim SW. Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer. Gene Ther. 2003;10(18):1535\u201342. https:\/\/doi.org\/10.1038\/sj.gt.3302034.","journal-title":"Gene Ther"},{"key":"421_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2019.07.024","volume":"309","author":"T Di Ianni","year":"2019","unstructured":"Di Ianni T, et al. Ultrasound\/microbubble-mediated targeted delivery of anticancer microRNA-loaded nanoparticles to deep tissues in pigs. J Control Release. 2019;309:1\u201310. https:\/\/doi.org\/10.1016\/j.jconrel.2019.07.024.","journal-title":"J Control Release"},{"issue":"3","key":"421_CR89","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1161\/CIRCRESAHA.107.148676","volume":"101","author":"H Leong-Poi","year":"2007","unstructured":"Leong-Poi H, et al. Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle. Circ Res. 2007;101(3):295\u2013303. https:\/\/doi.org\/10.1161\/CIRCRESAHA.107.148676.","journal-title":"Circ Res"},{"issue":"8","key":"421_CR90","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nnano.2012.84","volume":"7","author":"MN Holme","year":"2012","unstructured":"Holme MN, et al. Shear-stress sensitive lenticular vesicles for targeted drug delivery. Nat Nanotechnol. 2012;7(8):536\u201343. https:\/\/doi.org\/10.1038\/nnano.2012.84.","journal-title":"Nat Nanotechnol"},{"key":"421_CR91","doi-asserted-by":"publisher","unstructured":"Y. Chen et al., \u201c\u2018All in one\u2019 lipid-polymer nanodelivery system for gene therapy of ischemic diseases,\u201d Biomaterials, vol. 313, Feb. 2025, https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122799.","DOI":"10.1016\/j.biomaterials.2024.122799"}],"container-title":["Regenerative Engineering and Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40883-025-00421-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40883-025-00421-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40883-025-00421-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:13:31Z","timestamp":1769616811000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40883-025-00421-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["421"],"URL":"https:\/\/doi.org\/10.1007\/s40883-025-00421-0","relation":{},"ISSN":["2364-4133","2364-4141"],"issn-type":[{"value":"2364-4133","type":"print"},{"value":"2364-4141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}